With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.246047-72-3,(1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro(phenylmethylene)(tricyclohexylphosphine)ruthenium,as a common compound, the synthetic route is as follows.
Example4 Synthesis of the Complex 3 According to the Invention [0080] The commercially available complex G (1.0 g, 1.18 mmol) was placed in a flask, to which methylene chloride was added (24 ml). This was followed by adding the compound of the formula: (141 mg, 1.17 mmol) and tricyclohexylphosphine (330 mg, 1.18 mmol). The resulting solution was stirred at a temperature of 40 C. for 5 hours. The reaction mixture was introduced at the top of a chromatographic column packed with silica gel (eluent: ethyl acetate/cyclohexane, 0 to 10 vol. %). After evaporating the solvents, the complex 3 was obtained as a green solid (797 mg, 82% yield). The NMR data are consistent with Example 3., 246047-72-3
246047-72-3 (1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro(phenylmethylene)(tricyclohexylphosphine)ruthenium 11147261, aruthenium-catalysts compound, is more and more widely used in various fields.
Reference£º
Patent; Skowerski, Krzysztof; Bieniek, Michal; US2015/158896; (2015); A1;,
Highly efficient and robust molecular ruthenium catalysts for water oxidation
Catalysts | Special Issue : Ruthenium Catalysts – MDPI